🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 20 (from laksa087)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa020.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://www.dzif.de/en/covid-19-set-european-registry-coronavirus-patients\')), getAhrefsUnparsedNoserviceFromURL(\'https://www.dzif.de/en/covid-19-set-european-registry-coronavirus-patients\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/www.dzif.de\/en\/covid-19-set-european-registry-coronavirus-patients","crawl_time":1775772047,"first_indexed_time":1584781637,"http_code":200,"src_unparsed":"de,dzif!www,\/en\/covid-19-set-european-registry-coronavirus-patients s443","src_root_hash":"3727122061091664620","history_drop_reason":null,"meta_title":"COVID-19: Set up of European registry for coronavirus patients | German Center for Infection Research","meta_descriptions":["When do patients infected with the new"],"attrs_boilerpipe_text":"When do patients infected with the new\ncoronavirus\ndevelop severe symptoms and when do they develop mild courses of disease? What is the best possible treatment and which measures have been successful up to now? Scientists and doctors urgently need reliable clinical data to enable them to answer these and many other questions about the coronavirus. Consequently, the German Society of Infectious Diseases (DGI) initiated the establishment of a European case registry to collect clinical data of patients with\nSARS-CoV-2\ninfection. It is jointly being set up with the DZIF.\n“We have opted for this course of action as there has been a repeated call for free anonymised data,” explains Prof. Jörg Janne Vehreschild, DZIF scientist at the University Hospital of Cologne. He is coordinating the project, which is being supported by the ESCMID Emerging Infections Task Force. “This registry will also collect clinical data of patients who are no longer capable of giving their informed consent.”\nThe new registry,\nLean European Open Survey for SARS-CoV-2 Infected Patients,\nor LEOSS for short, will make all the data collected available to the scientific community for use in collaborative analyses. LEOSS is multilingual and open for implementation across the entire EU. An additional special feature of this registry is that the study will be self-managed by the participating centres. Multi-layered safety features will warrant strict anonymity, permitting patients who are no longer able to give their informed consent to be included in the registry.\n“The availability of palpable clinical data of patients in Europe can be pivotal in providing the best care possible for the anticipated high number of cases, including those who are critically ill,” Vehreschild emphasizes.\nInterested study centres and data analysts are invited to participate in LEOSS. Please visit\nhttps:\/\/leoss.net\nfor all further information and registration.  \nSource:\nDGI-Pressemitteilung","attrs_markdown":"[Skip to main content](https:\/\/www.dzif.de\/en\/covid-19-set-european-registry-coronavirus-patients#main-content)\n\n[![German Center for Infection Research](https:\/\/www.dzif.de\/themes\/custom\/dzif\/build\/images\/logo-en.svg)](https:\/\/www.dzif.de\/en \"Home\")\n\nMenü\n\n- [Research](https:\/\/www.dzif.de\/en\/research)\n  - Back\n  - [Bridging Topics](https:\/\/www.dzif.de\/en\/bridging-topics)\n  - [Research Areas](https:\/\/www.dzif.de\/en\/research-areas)\n  - [Infrastructures](https:\/\/www.dzif.de\/en\/infrastructures)\n  - [Working Groups](https:\/\/www.dzif.de\/en\/working-groups)\n  - [Projects](https:\/\/www.dzif.de\/en\/projects)\n  - [African Partner Institutions](https:\/\/www.dzif.de\/en\/infrastructure\/african-partner-institutions)\n  - [Clinical Trials](https:\/\/clinicalsite.org\/~dzif\/de\/cat\/2084#c2084 \"Externe Seiten\")\n  - [Publications](https:\/\/www.dzif.de\/en\/publications)\n- [Translation](https:\/\/www.dzif.de\/en\/translation)\n  - Back\n  - [Developing Medication](https:\/\/www.dzif.de\/en\/developing-medication)\n  - [Successful Translation](https:\/\/www.dzif.de\/en\/successful-translation)\n  - [Collaborations](https:\/\/www.dzif.de\/en\/partners)\n  - [German Centers for Health Research](https:\/\/www.dzif.de\/en\/german-centers-health-research)\n- [DZIF Academy](https:\/\/www.dzif.de\/en\/dzif-academy)\n- [Newsroom](https:\/\/www.dzif.de\/en\/newsroom)\n  - Back\n  - [News](https:\/\/www.dzif.de\/en\/news)\n  - [Media Center](https:\/\/www.dzif.de\/en\/mediathek)\n  - [Press Office](https:\/\/www.dzif.de\/en\/press-office)\n  - [Events](https:\/\/www.dzif.de\/en\/events)\n  - [Jobs](https:\/\/www.dzif.de\/en\/jobs)\n- [About us](https:\/\/www.dzif.de\/en\/about-us)\n  - Back\n  - [Portrait](https:\/\/www.dzif.de\/en\/portrait \"Porträt\")\n  - [DZIF Structure and Bodies](https:\/\/www.dzif.de\/en\/dzif-structure-and-bodies \"Struktur\")\n  - [Partner Sites](https:\/\/www.dzif.de\/en\/partner-sites)\n  - [Executive Board](https:\/\/www.dzif.de\/en\/executive-board \"Executive Board\")\n  - [DZIF Patient Advisory Board](https:\/\/www.dzif.de\/en\/dzif-patient-advisory-board)\n  - [Staff](https:\/\/www.dzif.de\/en\/staff)\n  - [Main Office](https:\/\/www.dzif.de\/en\/main-office)\n  - [Donations](https:\/\/www.dzif.de\/en\/donate-infection-research \"Aufruf zu Spenden\")\n\nSuche\n\nSuche\n\n- [De](https:\/\/www.dzif.de\/de\/covid-19-europaeisches-fallregister-fuer-coronavirus-patienten-im-aufbau \"Deutsch\")\n- \\|\n- [En](https:\/\/www.dzif.de\/en\/covid-19-set-european-registry-coronavirus-patients \"English\")\n\nMar 19 2020\n\nNews\n# COVID-19: Set up of European registry for coronavirus patients\n\n## Breadcrumb\n1. [Home](https:\/\/www.dzif.de\/en)\n2. [COVID-19: Set Up of European Registry For Coronavirus Patients](https:\/\/www.dzif.de\/en\/covid-19-set-european-registry-coronavirus-patients)\n\n[![LEOSS](https:\/\/www.dzif.de\/system\/files\/styles\/dzif_inline_66_dzif_xs_1x\/private\/image\/LEOSS%20Logo.png?h=4ddaff75&itok=UhPO2X5P) © LEOSS](https:\/\/www.dzif.de\/system\/files\/styles\/dzif_lightbox_dzif_xl_1x\/private\/image\/LEOSS%20Logo.png?h=4ddaff75&itok=jSRFDusJ \"Click to enlarge\")\n\n© LEOSS\n\n## Contact person\n[![Jörg-Janne Vehreschild](https:\/\/www.dzif.de\/system\/files\/styles\/dzif_portrait_small_dzif_xl_1x\/private\/image\/Prof_J_Vehreschild-Portrait.JPG?h=d4be38f4&itok=vppOEore)](https:\/\/www.dzif.de\/en\/about-us\/staff\/prof-dr-jorg-janne-vehreschild)\n\n### [Prof. Dr. Jörg Janne Vehreschild](https:\/\/www.dzif.de\/en\/about-us\/staff\/prof-dr-jorg-janne-vehreschild)\nUniversity Hospital Cologne\n\nGoethe University Frankfurt\n\nCoordinator Databases\n\n[Send mail](https:\/\/www.dzif.de\/en\/email\/node\/920\/teaser_box_33\/field_mail)\n\n**When do patients infected with the new [coronavirus](https:\/\/www.dzif.de\/en\/glossary\/coronavirus \"Coronaviruses are a family of RNA viruses that can infect both animals and humans. In humans they mainly cause respiratory tract diseases. They can run like harmless colds, but can also be fatal. \") develop severe symptoms and when do they develop mild courses of disease? What is the best possible treatment and which measures have been successful up to now? Scientists and doctors urgently need reliable clinical data to enable them to answer these and many other questions about the coronavirus. Consequently, the German Society of Infectious Diseases (DGI) initiated the establishment of a European case registry to collect clinical data of patients with [SARS-CoV-2](https:\/\/www.dzif.de\/en\/glossary\/sars-cov-2 \"SARS-CoV-2 is an RNA virus belonging to the coronavirus family. SARS-CoV-2 can trigger the respiratory tract disease called COVID-19.\") infection. It is jointly being set up with the DZIF.**\n\n“We have opted for this course of action as there has been a repeated call for free anonymised data,” explains Prof. Jörg Janne Vehreschild, DZIF scientist at the University Hospital of Cologne. He is coordinating the project, which is being supported by the ESCMID Emerging Infections Task Force. “This registry will also collect clinical data of patients who are no longer capable of giving their informed consent.”\n\nThe new registry, *Lean European Open Survey for SARS-CoV-2 Infected Patients,* or LEOSS for short, will make all the data collected available to the scientific community for use in collaborative analyses. LEOSS is multilingual and open for implementation across the entire EU. An additional special feature of this registry is that the study will be self-managed by the participating centres. Multi-layered safety features will warrant strict anonymity, permitting patients who are no longer able to give their informed consent to be included in the registry.\n\n“The availability of palpable clinical data of patients in Europe can be pivotal in providing the best care possible for the anticipated high number of cases, including those who are critically ill,” Vehreschild emphasizes.\n\nInterested study centres and data analysts are invited to participate in LEOSS. Please visit <https:\/\/leoss.net> for all further information and registration.\n\nSource: [DGI-Pressemitteilung](https:\/\/www.dgi-net.de\/leoss-europaeisches-fallregister-fuer-patientinnen-und-patienten-mit-sars-cov-2-infektion\/)\n\n## This may interest you as well\n[![The photo shows a woman wearing a mask receiving a vaccination in her arm from a person wearing blue gloves. The DZIF and Ethris logos can be seen in the corners of the image.](https:\/\/www.dzif.de\/system\/files\/styles\/dzif_teaser_tile_33_dzif_xl_1x\/private\/image\/PM%202026%20Ethris%20Kooperation.jpg?h=49952ddd&itok=X5MPdVU2)](https:\/\/www.dzif.de\/en\/ethris-and-german-center-infection-research-dzif-announce-strategic-collaboration-develop-mrna)\n\n© AdobeStock\/Konstantin Yuganov\/Ethris\/DZIF\n\n© AdobeStock\/Konstantin Yuganov\/Ethris\/DZIF\n\nFeb 9 2026\n\n## [Ethris and German Center for Infection Research (DZIF) announce strategic collaboration to develop mRNA-based vaccines](https:\/\/www.dzif.de\/en\/ethris-and-german-center-infection-research-dzif-announce-strategic-collaboration-develop-mrna)\nEthris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), today announced a strategic research\n\n[![Three small refrigerated glass bottles with labels indicating their contents.](https:\/\/www.dzif.de\/system\/files\/styles\/dzif_teaser_tile_33_dzif_xl_1x\/private\/image\/MERS-2_16-9.jpg?h=9ebad9a8&itok=HdwD4WdN)](https:\/\/www.dzif.de\/en\/preparedness-future-pandemics-mers-vaccine-candidate-shows-long-lasting-immune-response)\n\n© UKE\/Leonie Mayer\n\n© UKE\/Leonie Mayer\n\nJan 26 2026\n\n## [Preparedness for future pandemics: MERS vaccine candidate shows long-lasting immune response](https:\/\/www.dzif.de\/en\/preparedness-future-pandemics-mers-vaccine-candidate-shows-long-lasting-immune-response)\nA new study has shown for the first time that an experimental [vaccine](https:\/\/www.dzif.de\/en\/glossary\/vaccine \"A vaccine contains an antigen that is given to individuals in order to establish protective immunity against a particular infection. \") against Middle East Respiratory Syndrome ([MERS](https:\/\/www.dzif.de\/en\/glossary\/mers \"MERS stands for the Middle East Respiratory Syndrome and refers to an infection of the airways that is caused by the novel MERS coronavirus (MERS-CoV).\")) induces a stable and functional immune response in humans that persists for at\n\n[![Photo of a large crowd of people in a lecture hall, taken from a bird's eye view.](https:\/\/www.dzif.de\/system\/files\/styles\/dzif_teaser_tile_33_dzif_xl_1x\/private\/image\/Gruppenbild%20Jahrestagung%202025%20v2_0.jpg?h=ef5c6547&itok=QYCYyQ5o)](https:\/\/www.dzif.de\/en\/infection-research-age-antibiotic-resistance-gender-medicine-and-precision-medicine)\n\n© DZIF \/ Matthias Balk\n\n© DZIF \/ Matthias Balk\n\nJan 19 2026\n\n## [Infection research in the age of antibiotic resistance, gender medicine, and precision medicine](https:\/\/www.dzif.de\/en\/infection-research-age-antibiotic-resistance-gender-medicine-and-precision-medicine)\nOn February 23 and 24, 2026, experts from the German Center for Infection Research (DZIF) and the Paul-Ehrlich-Society for Infection Therapy (PEG) will meet at the Maritim Hotel in Bonn for their\n\nPrevious\n\nNext\n\n- Share on\n  - [LinkedIn](https:\/\/www.linkedin.com\/shareArticle?url=https%3A\/\/www.dzif.de\/en\/covid-19-set-european-registry-coronavirus-patients&title=COVID-19%3A%20Set%20up%20of%20European%20registry%20for%20coronavirus%20patients%20&mini=true \"Share on LinkedIn\")\n\n[Print](https:\/\/www.dzif.de\/en\/covid-19-set-european-registry-coronavirus-patients \"Print this page\")\n\n## Sitemap\n- [Research](https:\/\/www.dzif.de\/en\/research)\n- [Translation](https:\/\/www.dzif.de\/en\/translation)\n- [DZIF Academy](https:\/\/www.dzif.de\/en\/dzif-academy)\n- [Newsroom](https:\/\/www.dzif.de\/en\/newsroom)\n- [About us](https:\/\/www.dzif.de\/en\/about-us)\n\n## At one click\n- [Jobs](https:\/\/www.dzif.de\/en\/jobs)\n- [Media Centre](https:\/\/www.dzif.de\/en\/mediathek)\n- [Press releases](https:\/\/www.dzif.de\/en\/news?category=1)\n- [Press contact](https:\/\/www.dzif.de\/en\/press-office)\n- [Glossary](https:\/\/www.dzif.de\/en\/glossar)\n- [Donations](https:\/\/www.dzif.de\/en\/donate-infection-research)\n## Newsletter Subscription\n## Contact\nMain Office of the DZIF e. V.  \n Inhoffenstraße 7  \n 38124 Braunschweig  \n \n\n[Send mail](https:\/\/www.dzif.de\/en\/email\/block_content\/6\/full\/field_mail)\n\n## Fußbereichsmenü\n- [DZIF Portal (internal)](https:\/\/portal.dzif.de\/)\n- [Whistleblower system](https:\/\/www.dzif.de\/en\/whistleblower-system)\n- [Imprint](https:\/\/www.dzif.de\/en\/imprint)\n- [Privacy policy](https:\/\/www.dzif.de\/en\/privacy-policy)\n- [Log in](https:\/\/www.dzif.de\/en\/user\/login)\n- [Manage cookie consent](https:\/\/www.dzif.de\/en\/covid-19-set-european-registry-coronavirus-patients)\n\n![German Centers for Health Research](https:\/\/www.dzif.de\/themes\/custom\/dzif\/build\/images\/dzg-logo-2022.svg)\n\nSupported by the ![Federal Ministry of Research, Technology and Space ](https:\/\/www.dzif.de\/themes\/custom\/dzif\/build\/images\/logo-bmftr-en.svg) and the participating federal states","attrs_readable_markdown":"**When do patients infected with the new [coronavirus](https:\/\/www.dzif.de\/en\/glossary\/coronavirus \"Coronaviruses are a family of RNA viruses that can infect both animals and humans. In humans they mainly cause respiratory tract diseases. They can run like harmless colds, but can also be fatal. \") develop severe symptoms and when do they develop mild courses of disease? What is the best possible treatment and which measures have been successful up to now? Scientists and doctors urgently need reliable clinical data to enable them to answer these and many other questions about the coronavirus. Consequently, the German Society of Infectious Diseases (DGI) initiated the establishment of a European case registry to collect clinical data of patients with [SARS-CoV-2](https:\/\/www.dzif.de\/en\/glossary\/sars-cov-2 \"SARS-CoV-2 is an RNA virus belonging to the coronavirus family. SARS-CoV-2 can trigger the respiratory tract disease called COVID-19.\") infection. It is jointly being set up with the DZIF.**\n\n“We have opted for this course of action as there has been a repeated call for free anonymised data,” explains Prof. Jörg Janne Vehreschild, DZIF scientist at the University Hospital of Cologne. He is coordinating the project, which is being supported by the ESCMID Emerging Infections Task Force. “This registry will also collect clinical data of patients who are no longer capable of giving their informed consent.”\n\nThe new registry, *Lean European Open Survey for SARS-CoV-2 Infected Patients,* or LEOSS for short, will make all the data collected available to the scientific community for use in collaborative analyses. LEOSS is multilingual and open for implementation across the entire EU. An additional special feature of this registry is that the study will be self-managed by the participating centres. Multi-layered safety features will warrant strict anonymity, permitting patients who are no longer able to give their informed consent to be included in the registry.\n\n“The availability of palpable clinical data of patients in Europe can be pivotal in providing the best care possible for the anticipated high number of cases, including those who are critically ill,” Vehreschild emphasizes.\n\nInterested study centres and data analysts are invited to participate in LEOSS. Please visit [https:\/\/leoss.net](https:\/\/leoss.net\/) for all further information and registration.\n\nSource: [DGI-Pressemitteilung](https:\/\/www.dgi-net.de\/leoss-europaeisches-fallregister-fuer-patientinnen-und-patienten-mit-sars-cov-2-infektion\/)","meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

8 days ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	0.3 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://www.dzif.de/en/covid-19-set-european-registry-coronavirus-patients
Last Crawled	2026-04-09 22:00:47 (8 days ago)
First Indexed	2020-03-21 09:07:17 (6 years ago)
HTTP Status Code	200
Meta Title	COVID-19: Set up of European registry for coronavirus patients \| German Center for Infection Research
Meta Description	When do patients infected with the new
Meta Canonical	null
Boilerpipe Text	When do patients infected with the new coronavirus develop severe symptoms and when do they develop mild courses of disease? What is the best possible treatment and which measures have been successful up to now? Scientists and doctors urgently need reliable clinical data to enable them to answer these and many other questions about the coronavirus. Consequently, the German Society of Infectious Diseases (DGI) initiated the establishment of a European case registry to collect clinical data of patients with SARS-CoV-2 infection. It is jointly being set up with the DZIF. “We have opted for this course of action as there has been a repeated call for free anonymised data,” explains Prof. Jörg Janne Vehreschild, DZIF scientist at the University Hospital of Cologne. He is coordinating the project, which is being supported by the ESCMID Emerging Infections Task Force. “This registry will also collect clinical data of patients who are no longer capable of giving their informed consent.” The new registry, Lean European Open Survey for SARS-CoV-2 Infected Patients, or LEOSS for short, will make all the data collected available to the scientific community for use in collaborative analyses. LEOSS is multilingual and open for implementation across the entire EU. An additional special feature of this registry is that the study will be self-managed by the participating centres. Multi-layered safety features will warrant strict anonymity, permitting patients who are no longer able to give their informed consent to be included in the registry. “The availability of palpable clinical data of patients in Europe can be pivotal in providing the best care possible for the anticipated high number of cases, including those who are critically ill,” Vehreschild emphasizes. Interested study centres and data analysts are invited to participate in LEOSS. Please visit https://leoss.net for all further information and registration. Source: DGI-Pressemitteilung
Markdown	[Skip to main content](https://www.dzif.de/en/covid-19-set-european-registry-coronavirus-patients#main-content) [![German Center for Infection Research](https://www.dzif.de/themes/custom/dzif/build/images/logo-en.svg)](https://www.dzif.de/en "Home") Menü - [Research](https://www.dzif.de/en/research) - Back - [Bridging Topics](https://www.dzif.de/en/bridging-topics) - [Research Areas](https://www.dzif.de/en/research-areas) - [Infrastructures](https://www.dzif.de/en/infrastructures) - [Working Groups](https://www.dzif.de/en/working-groups) - [Projects](https://www.dzif.de/en/projects) - [African Partner Institutions](https://www.dzif.de/en/infrastructure/african-partner-institutions) - [Clinical Trials](https://clinicalsite.org/~dzif/de/cat/2084#c2084 "Externe Seiten") - [Publications](https://www.dzif.de/en/publications) - [Translation](https://www.dzif.de/en/translation) - Back - [Developing Medication](https://www.dzif.de/en/developing-medication) - [Successful Translation](https://www.dzif.de/en/successful-translation) - [Collaborations](https://www.dzif.de/en/partners) - [German Centers for Health Research](https://www.dzif.de/en/german-centers-health-research) - [DZIF Academy](https://www.dzif.de/en/dzif-academy) - [Newsroom](https://www.dzif.de/en/newsroom) - Back - [News](https://www.dzif.de/en/news) - [Media Center](https://www.dzif.de/en/mediathek) - [Press Office](https://www.dzif.de/en/press-office) - [Events](https://www.dzif.de/en/events) - [Jobs](https://www.dzif.de/en/jobs) - [About us](https://www.dzif.de/en/about-us) - Back - [Portrait](https://www.dzif.de/en/portrait "Porträt") - [DZIF Structure and Bodies](https://www.dzif.de/en/dzif-structure-and-bodies "Struktur") - [Partner Sites](https://www.dzif.de/en/partner-sites) - [Executive Board](https://www.dzif.de/en/executive-board "Executive Board") - [DZIF Patient Advisory Board](https://www.dzif.de/en/dzif-patient-advisory-board) - [Staff](https://www.dzif.de/en/staff) - [Main Office](https://www.dzif.de/en/main-office) - [Donations](https://www.dzif.de/en/donate-infection-research "Aufruf zu Spenden") Suche Suche - [De](https://www.dzif.de/de/covid-19-europaeisches-fallregister-fuer-coronavirus-patienten-im-aufbau "Deutsch") - \\| - [En](https://www.dzif.de/en/covid-19-set-european-registry-coronavirus-patients "English") Mar 19 2020 News # COVID-19: Set up of European registry for coronavirus patients ## Breadcrumb 1. [Home](https://www.dzif.de/en) 2. [COVID-19: Set Up of European Registry For Coronavirus Patients](https://www.dzif.de/en/covid-19-set-european-registry-coronavirus-patients) [![LEOSS](https://www.dzif.de/system/files/styles/dzif_inline_66_dzif_xs_1x/private/image/LEOSS%20Logo.png?h=4ddaff75&itok=UhPO2X5P) © LEOSS](https://www.dzif.de/system/files/styles/dzif_lightbox_dzif_xl_1x/private/image/LEOSS%20Logo.png?h=4ddaff75&itok=jSRFDusJ "Click to enlarge") © LEOSS ## Contact person [![Jörg-Janne Vehreschild](https://www.dzif.de/system/files/styles/dzif_portrait_small_dzif_xl_1x/private/image/Prof_J_Vehreschild-Portrait.JPG?h=d4be38f4&itok=vppOEore)](https://www.dzif.de/en/about-us/staff/prof-dr-jorg-janne-vehreschild) ### [Prof. Dr. Jörg Janne Vehreschild](https://www.dzif.de/en/about-us/staff/prof-dr-jorg-janne-vehreschild) University Hospital Cologne Goethe University Frankfurt Coordinator Databases [Send mail](https://www.dzif.de/en/email/node/920/teaser_box_33/field_mail) When do patients infected with the new [coronavirus](https://www.dzif.de/en/glossary/coronavirus "Coronaviruses are a family of RNA viruses that can infect both animals and humans. In humans they mainly cause respiratory tract diseases. They can run like harmless colds, but can also be fatal. ") develop severe symptoms and when do they develop mild courses of disease? What is the best possible treatment and which measures have been successful up to now? Scientists and doctors urgently need reliable clinical data to enable them to answer these and many other questions about the coronavirus. Consequently, the German Society of Infectious Diseases (DGI) initiated the establishment of a European case registry to collect clinical data of patients with [SARS-CoV-2](https://www.dzif.de/en/glossary/sars-cov-2 "SARS-CoV-2 is an RNA virus belonging to the coronavirus family. SARS-CoV-2 can trigger the respiratory tract disease called COVID-19.") infection. It is jointly being set up with the DZIF. “We have opted for this course of action as there has been a repeated call for free anonymised data,” explains Prof. Jörg Janne Vehreschild, DZIF scientist at the University Hospital of Cologne. He is coordinating the project, which is being supported by the ESCMID Emerging Infections Task Force. “This registry will also collect clinical data of patients who are no longer capable of giving their informed consent.” The new registry, Lean European Open Survey for SARS-CoV-2 Infected Patients, or LEOSS for short, will make all the data collected available to the scientific community for use in collaborative analyses. LEOSS is multilingual and open for implementation across the entire EU. An additional special feature of this registry is that the study will be self-managed by the participating centres. Multi-layered safety features will warrant strict anonymity, permitting patients who are no longer able to give their informed consent to be included in the registry. “The availability of palpable clinical data of patients in Europe can be pivotal in providing the best care possible for the anticipated high number of cases, including those who are critically ill,” Vehreschild emphasizes. Interested study centres and data analysts are invited to participate in LEOSS. Please visit <https://leoss.net> for all further information and registration. Source: [DGI-Pressemitteilung](https://www.dgi-net.de/leoss-europaeisches-fallregister-fuer-patientinnen-und-patienten-mit-sars-cov-2-infektion/) ## This may interest you as well [![The photo shows a woman wearing a mask receiving a vaccination in her arm from a person wearing blue gloves. The DZIF and Ethris logos can be seen in the corners of the image.](https://www.dzif.de/system/files/styles/dzif_teaser_tile_33_dzif_xl_1x/private/image/PM%202026%20Ethris%20Kooperation.jpg?h=49952ddd&itok=X5MPdVU2)](https://www.dzif.de/en/ethris-and-german-center-infection-research-dzif-announce-strategic-collaboration-develop-mrna) © AdobeStock/Konstantin Yuganov/Ethris/DZIF © AdobeStock/Konstantin Yuganov/Ethris/DZIF Feb 9 2026 ## [Ethris and German Center for Infection Research (DZIF) announce strategic collaboration to develop mRNA-based vaccines](https://www.dzif.de/en/ethris-and-german-center-infection-research-dzif-announce-strategic-collaboration-develop-mrna) Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), today announced a strategic research [![Three small refrigerated glass bottles with labels indicating their contents.](https://www.dzif.de/system/files/styles/dzif_teaser_tile_33_dzif_xl_1x/private/image/MERS-2_16-9.jpg?h=9ebad9a8&itok=HdwD4WdN)](https://www.dzif.de/en/preparedness-future-pandemics-mers-vaccine-candidate-shows-long-lasting-immune-response) © UKE/Leonie Mayer © UKE/Leonie Mayer Jan 26 2026 ## [Preparedness for future pandemics: MERS vaccine candidate shows long-lasting immune response](https://www.dzif.de/en/preparedness-future-pandemics-mers-vaccine-candidate-shows-long-lasting-immune-response) A new study has shown for the first time that an experimental [vaccine](https://www.dzif.de/en/glossary/vaccine "A vaccine contains an antigen that is given to individuals in order to establish protective immunity against a particular infection. ") against Middle East Respiratory Syndrome ([MERS](https://www.dzif.de/en/glossary/mers "MERS stands for the Middle East Respiratory Syndrome and refers to an infection of the airways that is caused by the novel MERS coronavirus (MERS-CoV).")) induces a stable and functional immune response in humans that persists for at [![Photo of a large crowd of people in a lecture hall, taken from a bird's eye view.](https://www.dzif.de/system/files/styles/dzif_teaser_tile_33_dzif_xl_1x/private/image/Gruppenbild%20Jahrestagung%202025%20v2_0.jpg?h=ef5c6547&itok=QYCYyQ5o)](https://www.dzif.de/en/infection-research-age-antibiotic-resistance-gender-medicine-and-precision-medicine) © DZIF / Matthias Balk © DZIF / Matthias Balk Jan 19 2026 ## [Infection research in the age of antibiotic resistance, gender medicine, and precision medicine](https://www.dzif.de/en/infection-research-age-antibiotic-resistance-gender-medicine-and-precision-medicine) On February 23 and 24, 2026, experts from the German Center for Infection Research (DZIF) and the Paul-Ehrlich-Society for Infection Therapy (PEG) will meet at the Maritim Hotel in Bonn for their Previous Next - Share on - [LinkedIn](https://www.linkedin.com/shareArticle?url=https%3A//www.dzif.de/en/covid-19-set-european-registry-coronavirus-patients&title=COVID-19%3A%20Set%20up%20of%20European%20registry%20for%20coronavirus%20patients%20&mini=true "Share on LinkedIn") [Print](https://www.dzif.de/en/covid-19-set-european-registry-coronavirus-patients "Print this page") ## Sitemap - [Research](https://www.dzif.de/en/research) - [Translation](https://www.dzif.de/en/translation) - [DZIF Academy](https://www.dzif.de/en/dzif-academy) - [Newsroom](https://www.dzif.de/en/newsroom) - [About us](https://www.dzif.de/en/about-us) ## At one click - [Jobs](https://www.dzif.de/en/jobs) - [Media Centre](https://www.dzif.de/en/mediathek) - [Press releases](https://www.dzif.de/en/news?category=1) - [Press contact](https://www.dzif.de/en/press-office) - [Glossary](https://www.dzif.de/en/glossar) - [Donations](https://www.dzif.de/en/donate-infection-research) ## Newsletter Subscription ## Contact Main Office of the DZIF e. V. Inhoffenstraße 7 38124 Braunschweig [Send mail](https://www.dzif.de/en/email/block_content/6/full/field_mail) ## Fußbereichsmenü - [DZIF Portal (internal)](https://portal.dzif.de/) - [Whistleblower system](https://www.dzif.de/en/whistleblower-system) - [Imprint](https://www.dzif.de/en/imprint) - [Privacy policy](https://www.dzif.de/en/privacy-policy) - [Log in](https://www.dzif.de/en/user/login) - [Manage cookie consent](https://www.dzif.de/en/covid-19-set-european-registry-coronavirus-patients) ![German Centers for Health Research](https://www.dzif.de/themes/custom/dzif/build/images/dzg-logo-2022.svg) Supported by the ![Federal Ministry of Research, Technology and Space ](https://www.dzif.de/themes/custom/dzif/build/images/logo-bmftr-en.svg) and the participating federal states
Readable Markdown	When do patients infected with the new [coronavirus](https://www.dzif.de/en/glossary/coronavirus "Coronaviruses are a family of RNA viruses that can infect both animals and humans. In humans they mainly cause respiratory tract diseases. They can run like harmless colds, but can also be fatal. ") develop severe symptoms and when do they develop mild courses of disease? What is the best possible treatment and which measures have been successful up to now? Scientists and doctors urgently need reliable clinical data to enable them to answer these and many other questions about the coronavirus. Consequently, the German Society of Infectious Diseases (DGI) initiated the establishment of a European case registry to collect clinical data of patients with [SARS-CoV-2](https://www.dzif.de/en/glossary/sars-cov-2 "SARS-CoV-2 is an RNA virus belonging to the coronavirus family. SARS-CoV-2 can trigger the respiratory tract disease called COVID-19.") infection. It is jointly being set up with the DZIF. “We have opted for this course of action as there has been a repeated call for free anonymised data,” explains Prof. Jörg Janne Vehreschild, DZIF scientist at the University Hospital of Cologne. He is coordinating the project, which is being supported by the ESCMID Emerging Infections Task Force. “This registry will also collect clinical data of patients who are no longer capable of giving their informed consent.” The new registry, Lean European Open Survey for SARS-CoV-2 Infected Patients, or LEOSS for short, will make all the data collected available to the scientific community for use in collaborative analyses. LEOSS is multilingual and open for implementation across the entire EU. An additional special feature of this registry is that the study will be self-managed by the participating centres. Multi-layered safety features will warrant strict anonymity, permitting patients who are no longer able to give their informed consent to be included in the registry. “The availability of palpable clinical data of patients in Europe can be pivotal in providing the best care possible for the anticipated high number of cases, including those who are critically ill,” Vehreschild emphasizes. Interested study centres and data analysts are invited to participate in LEOSS. Please visit [https://leoss.net](https://leoss.net/) for all further information and registration. Source: [DGI-Pressemitteilung](https://www.dgi-net.de/leoss-europaeisches-fallregister-fuer-patientinnen-und-patienten-mit-sars-cov-2-infektion/)
Shard	20 (laksa)
Root Hash	3727122061091664620
Unparsed URL	de,dzif!www,/en/covid-19-set-european-registry-coronavirus-patients s443